[在腹发作中输入类固醇:一个病例报告]
Chaim Chaimoff1, Boris Sapojnikov2, Eduard Reiss3
1Surgery Department (in pension).
Harefuah
|July 24, 2025
概括
静脉注射 (IV) 类固醇可以成为严重发作的关键干预措施. 本案例报告强调了其在管理耐性腹腔疾病恶化中的有效使用.
科学领域:
- 胃肠病学 胃肠病学
- 免疫学 免疫学 免疫学
- 内部医学 内部医学
背景情况:
- 结肠病是一种自身免疫性疾病,由摄入质引发.
- 严重的腹发作可能导致严重的发病率,需要密集管理.
- 静脉注射 (IV) 类固醇治疗是耐火病例的潜在治疗方法.
研究的目的:
- 报告在患有严重腹发作的患者中静脉注射类固醇的病例.
- 评估这种治疗干预的有效性和安全性.
- 讨论皮质类固醇在治疗急性,严重的病恶化中的潜在作用.
主要方法:
- 一份单一病例报告,详细说明患有腹腔疾病的患者的临床表现,诊断工作和治疗.
- 在严重发作期间,静脉注射皮质类固醇作为治疗干预措施.
- 监测患者对治疗的反应,包括症状的消失和相关的临床标志物.
主要成果:
- 该患者经历了一次严重的乳发作,不耐标准治疗.
- 静脉注射类固醇的使用导致了急性发作的快速症状改善和解决.
- 在皮质类固醇治疗期间或之后没有观察到任何显著的不良事件.
结论:
- 静脉输入的皮质类固醇治疗可能是严重,耐火性腹发作的一种可行的治疗选择.
- 需要进一步的研究,包括更大的研究,以证实这种方法的有效性和安全性.
- 这一案例凸显了考虑复杂的乳病表现的替代治疗策略的重要性.
相关概念视频
Drugs for Treatment of Crohn's Disease in IBD Using Glucocorticoids
203
Glucocorticoids, a class of anti-inflammatory drugs, are pivotal in treating moderate to severe Crohn's disease by inducing remission. They exhibit their anti-inflammatory action by inhibiting the production of inflammatory cytokines such as tumor necrosis factor (TNF)-α, interleukin (IL)-1, and chemokines like IL-8. In addition, they reduce the expression of inflammatory cell adhesion molecules and inhibit gene transcription of nitric oxide synthase, phospholipase A2, cyclooxygenase-2...
203
Drugs for Treatment of Ulcerative Colitis in IBD
239
Ulcerative colitis is a chronic inflammatory condition primarily affecting the colon and rectum. The primary drugs used in the treatment of ulcerative colitis are aminosalicylates. They exhibit anti-inflammatory and immunosuppressive properties. They modulate inflammatory mediators and inhibit the activity of nuclear factor κB (NF-κB). Aminosalicylates also reduce inflammation by inhibiting prostaglandin and leukotriene production and decreasing neutrophil chemotaxis and superoxide...
239
Inflammatory Bowel Disease IV: Pharmacological Management
193
Upon diagnosis, managing Inflammatory Bowel Disease (IBD) involves addressing several crucial aspects. The primary goals include resting the bowel, correcting malnutrition, and providing symptomatic relief. Resting the bowel may consist of medications to reduce inflammation and promote healing. Correcting malnutrition is essential, often requiring dietary adjustments and nutritional supplements. Symptomatic relief aims to ease pain, diarrhea, and other discomforts in IBD.
Pharmacologic...
Pharmacologic...
193
Inflammatory Bowel Disease III: Diagnostic Studies and Management I-Nutritional Therapy
422
Various diagnostic tests are employed in the diagnostic process for Inflammatory Bowel Disease (IBD), particularly to differentiate between Crohn's disease and ulcerative colitis.
Diagnostic studies
A colonoscopy is the definitive screening test, distinguishing ulcerative colitis from other colon diseases with similar symptoms. During a colonoscopy test, inflamed mucosa with exudate ulcerations can be observed, and biopsies are taken to determine the histologic characteristics of the...
Diagnostic studies
A colonoscopy is the definitive screening test, distinguishing ulcerative colitis from other colon diseases with similar symptoms. During a colonoscopy test, inflamed mucosa with exudate ulcerations can be observed, and biopsies are taken to determine the histologic characteristics of the...
422
Drugs for Treatment of Crohn's Disease in IBD Using Immunomodulatory Agents
271
Crohn's disease is an inflammatory bowel disorder marked by chronic inflammation of the GI tract. Various treatment strategies for Crohn's disease are employed, such as immunomodulatory agents, glucocorticoids, and biologics or anti-TNF therapy. Azathioprine (Imuran), a commonly used immunomodulatory drug for Crohn's disease, is converted in the body to mercaptopurine, which inhibits purine biosynthesis and cell proliferation. Both are utilized in severe cases of Inflammatory Bowel...
271
Gastritis III: Clinical Manifestations and Management
481
The clinical manifestations of gastritis can vary depending on the cause and type of gastritis, but some common symptoms may include the following.
Clinical manifestations of acute gastritis
The patient with acute gastritis may have a rapid onset of symptoms, such as epigastric pain or discomfort, dyspepsia, anorexia, hiccups, or nausea and vomiting, which can last from a few hours to a few days. Erosive or hemorrhagic gastritis may cause bleeding, which may manifest as blood in vomit or as...
Clinical manifestations of acute gastritis
The patient with acute gastritis may have a rapid onset of symptoms, such as epigastric pain or discomfort, dyspepsia, anorexia, hiccups, or nausea and vomiting, which can last from a few hours to a few days. Erosive or hemorrhagic gastritis may cause bleeding, which may manifest as blood in vomit or as...
481


